Fetal Left Cardiac Malformations

2020 ◽  
pp. 220-253
Author(s):  
Gabriele Tonni
2008 ◽  
Vol 18 (S2) ◽  
pp. 256-264 ◽  
Author(s):  
Heather Dickerson ◽  
David S. Cooper ◽  
Paul A. Checchia ◽  
David P. Nelson

AbstractA complication is an event or occurrence that is associated with a disease or a healthcare intervention, is a departure from the desired course of events, and may cause, or be associated with, suboptimal outcome. A complication does not necessarily represent a breech in the standard of care that constitutes medical negligence or medical malpractice. An operative or procedural complication is any complication, regardless of cause, occurring (1) within 30 days after surgery or intervention in or out of the hospital, or (2) after 30 days during the same hospitalization subsequent to the operation or intervention. Operative and procedural complications include both intraoperative/intraprocedural complications and postoperative/postprocedural complications in this time interval.The MultiSocietal Database Committee for Pediatric and Congenital Heart Disease has set forth a comprehensive list of complications associated with the treatment of patients with congenital cardiac disease, related to cardiac, pulmonary, renal, haematological, infectious, neurological, gastrointestinal, and endocrinal systems, as well as those related to the management of anaesthesia and perfusion, and the transplantation of thoracic organs. The objective of this manuscript is to examine the definitions of operative morbidity as they relate specifically to the endocrine system. These specific definitions and terms will be used to track morbidity associated with surgical and transcatheter interventions and other forms of therapy in a common language across many separate databases.As surgical survival in children with congenital cardiac disease has improved in recent years, focus has necessarily shifted to reducing the morbidity of congenital cardiac malformations and their treatment. A comprehensive list of endocrinal complications is presented. This list is a component of a systems-based compendium of complications that will standardize terminology and thereby allow the study and quantification of morbidity in patients with congenital cardiac malformations. Clinicians caring for patients with congenital cardiac disease will be able to use this list for databases, initiatives to improve quality, reporting of complications, and comparing strategies of treatment.


The Lancet ◽  
1991 ◽  
Vol 337 (8744) ◽  
pp. 804 ◽  
Author(s):  
Domenico Licata ◽  
Ettore Garzena ◽  
Barbara Stasiowska ◽  
Michael Mostert ◽  
Claudio Fabris

2008 ◽  
Vol 29 (3) ◽  
pp. 604-608 ◽  
Author(s):  
S. V. Thomas ◽  
B. Ajaykumar ◽  
K. Sindhu ◽  
E. Francis ◽  
N. Namboodiri ◽  
...  

PEDIATRICS ◽  
1959 ◽  
Vol 24 (4) ◽  
pp. 522-522
Author(s):  
S. G.

Cardiovascular lesions are known to be frequently associated with arachnodactyly. The most common pathologic finding is cystic medionecrosis, particularly affecting the aorta, which often gives rise to aneurysm formation. Congenital cardiac malformations have also been described in patients with arachnodactyly; the more common lesions encountered are coarctation of the aorta and septal defects. From his experience at the Gronigen Clinic, Netherlands, the author reports another, but less frequently observed, finding of myocardial hypertrophy and fibrosis, in the absence of other cardiovascular pathology; this lesion leads eventually to cardiac decompensation and demise. The term "arachnodactyly heart" is proposed to designate the primary myocardial pathology in this hereditary disease.


PEDIATRICS ◽  
1980 ◽  
Vol 65 (6) ◽  
pp. 1174-1176
Author(s):  
Saul Krugman

Sixteen years have elapsed since the last major epidemic of rubella in the United States. Prior to 1964, extensive outbreaks occurred at about six- to nine-year intervals. These outbreaks were associated with the birth of many thousands of infants with one or more of the following defects: cataracts, deafness, cardiac malformations, and brain damage causing mental retardation, cerebral palsy, or severe behavior disorders. In addition, many pregnancies were terminated by spontaneous or therapeutic abortions. This devastating "rubella problem" provided the motivation for the development of rubella vaccine. The live attenuated rubella vaccine was licensed for use in 1969—two to four years before the next anticipated epidemic.


PEDIATRICS ◽  
1967 ◽  
Vol 40 (3) ◽  
pp. 478-479
Author(s):  
WELTON M. GERSONY

This book evolved from a recent symposium on the circulatory problems of the newborn sponsored by the Chicago Heart Association. Participating in the symposium were physicians eminently qualified in neonatal cardiopulmonary physiology and surgery. The papers are organized into six broad topics, which initially review the course of physiologic events from the fetus to the infant, then proceed to a consideration of current information related to the responses of the neonatal circulatory system to cardiac malformations.


Sign in / Sign up

Export Citation Format

Share Document